首页> 美国卫生研究院文献>Computational and Structural Biotechnology Journal >AtbPpred: A Robust Sequence-Based Prediction of Anti-Tubercular Peptides Using Extremely Randomized Trees
【2h】

AtbPpred: A Robust Sequence-Based Prediction of Anti-Tubercular Peptides Using Extremely Randomized Trees

机译:AtbPpred:使用极端随机树基于鲁棒的基于序列的抗结核肽的预测。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mycobacterium tuberculosis is one of the most dangerous pathogens in humans. It acts as an etiological agent of tuberculosis (TB), infecting almost one-third of the world's population. Owing to the high incidence of multidrug-resistant TB and extensively drug-resistant TB, there is an urgent need for novel and effective alternative therapies. Peptide-based therapy has several advantages, such as diverse mechanisms of action, low immunogenicity, and selective affinity to bacterial cell envelopes. However, the identification of anti-tubercular peptides (AtbPs) via experimentation is laborious and expensive; hence, the development of an efficient computational method is necessary for the prediction of AtbPs prior to both in vitro and in vivo experiments. To this end, we developed a two-layer machine learning (ML)-based predictor called AtbPpred for the identification of AtbPs. In the first layer, we applied a two-step feature selection procedure and identified the optimal feature set individually for nine different feature encodings, whose corresponding models were developed using extremely randomized tree (ERT). In the second-layer, the predicted probability of AtbPs from the above nine models were considered as input features to ERT and developed the final predictor. AtbPpred respectively achieved average accuracies of 88.3% and 87.3% during cross-validation and an independent evaluation, which were ~8.7% and 10.0% higher than the state-of-the-art method. Furthermore, we established a user-friendly webserver which is currently available at . We anticipate that this predictor could be useful in the high-throughput prediction of AtbPs and also provide mechanistic insights into its functions.
机译:结核分枝杆菌是人类中最危险的病原体之一。它是结核病的病原体,几乎感染了世界三分之一的人口。由于多药耐药结核病和广泛耐药结核病的高发,迫切需要新颖有效的替代疗法。基于肽的疗法具有多种优势,例如多种作用机制,低免疫原性和对细菌细胞膜的选择性亲和力。然而,通过实验鉴定抗结核肽(AtbPs)既费力又昂贵。因此,在体外和体内实验之前,开发一种有效的计算方法对于预测AtbP是必要的。为此,我们开发了一种基于两层机器学习(ML)的预测器,称为AtbPpred,用于识别AtbP。在第一层中,我们应用了两步特征选择过程,并针对9种不同特征编码分别确定了最佳特征集,其相应模型是使用极度随机树(ERT)开发的。在第二层中,来自以上九个模型的AtbPs的预测概率被视为ERT的输入特征,并开发了最终的预测因子。在交叉验证和独立评估中,AtbPpred的平均准确度分别达到88.3%和87.3%,比最新方法高出约8.7%和10.0%。此外,我们还建立了一个用户友好的网络服务器,该服务器目前可在上找到。我们预计该预测变量可能对AtbPs的高通量预测有用,并且还可以提供有关其功能的机械洞察力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号